Clinical Trials Directory

Trials / Completed

CompletedNCT00503659

Comparison of Two Methods of Bronchial Methacholine Provocation

Comparison of Two Methods of Bronchial Methacholine Provocation: PC 20 FEV1 Versus PD 20 FEV1

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
12 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is meant to compare two routine diagnostic approaches in patients with bronchial asthma. Patients are challenged with methacholine in order to measure their bronchial response. We compare the evaluation of the effects of incremental concentrations versus incremental dosages.

Detailed description

Bronchial methacholine challenge is well established in asthma diagnostic and research purposes. ATS guidelines provide a short five-breath dosimeter protocol using a five-step dilution schedule. The Viasys APS system enables a feasible and less time consuming provocation with incremental dosages. In 48 young adults with bronchial hyperreactivity (BHR) the ATS-protocol with a five-step protocol using a single dilution of 16 mg/ml methacholine should be compared.

Conditions

Interventions

TypeNameDescription
PROCEDUREBronchial methacholine provocationA short five-breath dosimeter protocol using a five-step dilution schedule according to ATS guidelines (0.0625, 0.25, 1, 4, 16 mg/ml methacholine)
PROCEDUREBronchial methacholine provocationA five-step protocol using a single dilution of 16 mg/ml methacholine (0.01, 0.1, 0.4, 0.8, 1.6 mg)

Timeline

Start date
2007-02-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2007-07-19
Last updated
2011-10-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00503659. Inclusion in this directory is not an endorsement.